For the quarter ending 2026-03-31, SMMT has $647,856K in assets. $101,924K in debts. $106,515K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 106,515 | 225,266 | 238,554 | 297,872 |
| Restricted cash | 316 | 316 | 321 | 319 |
| Short-term investments | 492,216 | 488,182 | 0 | 0 |
| Prepaid expenses and other current assets | 17,551 | 6,537 | 7,591 | 11,049 |
| Total current assets | 616,598 | 720,301 | 246,466 | 309,240 |
| Property and equipment, net | 1,664 | 1,059 | 810 | 690 |
| Operating lease right-of-use assets | 19,398 | 20,616 | 5,420 | 5,552 |
| Goodwill | 1,965 | 2,001 | 1,999 | 2,039 |
| Other assets | 8,231 | 7,205 | 7,034 | 6,516 |
| Total assets | 647,856 | 751,182 | 261,729 | 324,037 |
| Accounts payable | 27,549 | 20,292 | 22,245 | 22,982 |
| Accrued liabilities | 44,317 | 32,100 | 27,042 | 26,148 |
| Accrued compensation | 7,073 | 14,925 | 10,965 | 6,592 |
| Operating lease liabilities, current portion | 3,179 | 3,388 | 2,720 | 3,118 |
| Other current liabilities | 1,148 | 2,283 | 1,956 | 1,485 |
| Total current liabilities | 83,266 | 72,988 | 64,928 | 60,325 |
| Operating lease liabilities, net of current portion | 16,859 | 17,502 | 2,708 | 2,435 |
| Other non-current liabilities | 1,799 | 1,832 | 1,830 | 1,838 |
| Total liabilities | 101,924 | 92,322 | 69,466 | 64,598 |
| Common stock, 0.01 par value 1,000,000,000 shares authorized 776,017,474 and 775,371,200 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 7,760 | 7,754 | 7,444 | 7,428 |
| Additional paid-in capital | 3,024,387 | 2,947,805 | 2,262,515 | 2,097,957 |
| Accumulated other comprehensive loss | -2,632 | -2,540 | -2,709 | -2,752 |
| Accumulated deficit | -2,483,583 | -2,294,159 | -2,074,987 | -1,843,194 |
| Total stockholders' equity | 545,932 | 658,860 | 192,263 | 259,439 |
| Total liabilities and stockholders' equity | 647,856 | 751,182 | 261,729 | 324,037 |
Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. (SMMT)